Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$86.42 - $109.81 $80,370 - $102,123
-930 Reduced 18.44%
4,114 $433,000
Q4 2020

Feb 10, 2021

SELL
$67.0 - $84.39 $9,313 - $11,730
-139 Reduced 2.68%
5,044 $369,000
Q3 2020

Nov 10, 2020

SELL
$55.23 - $79.93 $43,466 - $62,904
-787 Reduced 13.18%
5,183 $403,000
Q2 2020

Aug 17, 2020

BUY
$30.2 - $56.98 $180,294 - $340,170
5,970 New
5,970 $332,000

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Covenant Partners, LLC Portfolio

Follow Covenant Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covenant Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Covenant Partners, LLC with notifications on news.